Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
Public ClinicalTrials.gov record NCT00028327. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Study to Evaluate Immediate Potent Antiretroviral Therapy for HIV-Infected Subjects With CD4 Cell Counts Less Than 350 Cells/mm3 Admitted to Intensive Care Areas With an AIDS-Defining Illness, Pneumonia, or Sepsis
Study identification
- NCT ID
- NCT00028327
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- Lamivudine/Zidovudine Drug
- Nelfinavir mesylate Drug
- Efavirenz Drug
- Lamivudine Drug
- Zidovudine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Jun 30, 2004
- Completion
- Not listed
- Last update posted
- Mar 1, 2011
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of Southern California | Los Angeles | California | 90033-1079 | — |
| Univ of California, San Diego | San Diego | California | 92103 | — |
| Univ of California San Francisco | San Francisco | California | 94110 | — |
| Univ of Miami School of Medicine | Miami | Florida | 331361013 | — |
| Johns Hopkins Hosp | Baltimore | Maryland | 21287 | — |
| Washington Univ School of Medicine | St Louis | Missouri | 63108 | — |
| Beth Israel Med Ctr | New York | New York | 10003 | — |
| Duke Univ Med Ctr | Durham | North Carolina | 27710 | — |
| Univ of Washington | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00028327, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2011 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00028327 live on ClinicalTrials.gov.